Search the Newsreel

International Flavors & Fragrances Inc (IFF) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

RenovoRx Inc (RNXT) Stock News Today

International Flavors & Fragrances (IFF) holder files to sell 1,000 shares

An International Flavors & Fragrances (IFF) stockholder has filed a Form 144 to sell 1,000 shares of common stock, valued at $85,000, on or after August 7, 2026, via Fidelity Brokerage Services LLC on the NYSE. The filing also details prior and future restricted …

AbbVie Takes Over #60 Spot From International Flavors & Fragrances

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, AbbVie Inc (Symbol: ABBV) has taken over the #60 spot from International Flavors & Fragrances Inc. (Symbol: IFF), according to ETF Channel. Below is a chart …

Deutsche Bank Adjusts International Flavors & Fragrances PT to $100 From $90, Maintains Buy Rating

Deutsche Bank has increased its price target for International Flavors & Fragrances (IFF) to $100 from $90, while reiterating a "Buy" rating on the stock. The article indicates that IFF generally holds an "overweight" rating with an average price target. However, access to the …

Vornado Realty Trust $VNO Shares Purchased by California State Teachers Retirement System

INTERNATIONAL FLAVORS & FRAGRANCES INC. : CITIGROUP RAISES TARGET PRICE TO $101 FROM $88

Citigroup has raised its target price for International Flavors & Fragrances Inc. (IFF.N) to $101 from $88. This update reflects an adjusted outlook from the financial institution regarding the company's valuation. The news is provided by Reuters.

RenovoRx’s RenovoCath used in sarcoma treatment for first time By Investing.com

RenovoRx Inc. announced that its RenovoCath drug-delivery device was used commercially for the first time to treat a sarcoma patient at CARTI Cancer Center. This marks an expansion beyond the company's prior focus on pancreatic cancer, demonstrating the device's potential for local chemotherapy delivery …

International Flavors & Fragrances (NYSE:IFF) Price Target Raised to $91.00

UBS Group has raised its price target for International Flavors & Fragrances (NYSE:IFF) to $91.00 from $84.00, maintaining a "neutral" rating despite the company's recent earnings per share and revenue missing expectations. The analyst consensus is a "Moderate Buy" with an average target of …

IFF (ticker: IFF) investor files to sell 8,825 shares worth $754,969

An investor in International Flavors & Fragrances Inc. (IFF) has filed a notice to sell 8,825 shares of common stock, valued at $754,969.04, through Fidelity Brokerage Services LLC. The shares were accumulated over time through restricted stock vesting compensation awards from 2017 to 2025. …

International Flavors & Fragrances (IFF) Stock Looks Below Fair Value But Above Fair Value On Earnings

Vor Biopharma Inc (VOR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Vor Biopharma Inc (VOR), highlighting analyst ratings and future growth estimates. Nine analysts have given VOR a "Buy" rating with a target price of USD 37.875, representing a potential upside of 59.81%. The forecast also includes details …

FMR LLC shows 9.1% Vor Biopharma (VOR) stake in Schedule 13G

FMR LLC has disclosed a 9.1% beneficial ownership stake in Vor Biopharma Inc. (VOR), amounting to 4,932,149 shares of common stock as of June 30, 2026. The filing indicates FMR LLC holds sole dispositive power and nearly all sole voting power over these shares. …

International Flavors & Fragrances (NYSE:IFF) Cut to Hold at Vertical Research

Vertical Research downgraded International Flavors & Fragrances (IFF) from "buy" to "hold," setting a new price target of $93, indicating a potential 5.6% upside. This comes after IFF missed Q2 earnings and revenue expectations, reporting $0.82 EPS against a $1.07 consensus and $1.95 billion …

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

RenovoRx, Inc. announced the first commercial clinical use of its FDA-cleared RenovoCath device for drug delivery in treating a sarcoma patient at the CARTI Cancer Center. This milestone demonstrates the potential for RenovoCath to expand beyond pancreatic cancer to other solid tumors for localized …

A Sarcoma Patient Is Receiving Local Chemotherapy via RenovoCath

RenovoRx (Nasdaq: RNXT) announced the first commercial clinical use of its RenovoCath device for localized chemotherapy delivery in a sarcoma patient at CARTI Cancer Center. This marks an expansion of the device's application beyond pancreatic cancer, demonstrating its potential for treating other solid tumors …

Vornado Realty Trust (NYSE:VNO) Given New $44.00 Price Target at Piper Sandler

Piper Sandler has increased its price target for Vornado Realty Trust (NYSE:VNO) to $44.00 from $42.00, maintaining a "neutral" rating, which suggests a 9.1% upside. Despite this, the stock fell 1.4% to $40.32 after reporting quarterly EPS of $0.08, significantly missing the consensus estimate …

Ladenburg Thalmann Maintains Vornado Realty Trust(VNO.US) With Buy Rating, Raises Target Price to $50

Ladenburg Thalmann has reiterated its Buy rating for Vornado Realty Trust (VNO.US) and increased the price target to $50. This adjustment reflects the firm's continued confidence in the real estate company's performance and future prospects. Investors will likely view this updated rating and target …

International Flavors & Fragrances Inc (IFF) (Q2 2026) Earnings Call Highlights: Strategic ...

International Flavors & Fragrances Inc (IFF) reported strong Q2 2026 results with 6% sales growth and significant free cash flow generation, driven by volume growth and productivity gains across all segments. The company is strategically divesting its Food Ingredients business to focus on higher-margin …

A Quick Look at Today's Ratings for Vornado Realty Trust(VNO.US), With a Forecast Between $32 to $45

This article provides a quick overview of analyst ratings for Vornado Realty Trust (VNO.US), noting a forecast price range between $32 and $45. The information is presented without further details in this particular content.

Por que as ações da International Flavors & Fragrances estão subindo hoje? - Investing.com Brasil

IFF Poised for Long-Term Growth From Specialty Taste, Scent, and Health and Biosciences Businesses

International Flavors & Fragrances (IFF) is positioned for long-term growth, driven by its specialty taste, scent, and health and biosciences divisions. The company's portfolio has evolved through strategic acquisitions, including DuPont's nutrition and biosciences business and Frutarom. Analyst Seth Goldstein reiterated this outlook, noting …

Vornado Realty Trust $VNO Shares Bought by Quantinno Capital Management LP

International Flavors & Fragrances Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:IFF) 2026-08-06

International Flavors & Fragrances Inc. (IFF) published its Q2 2026 earnings call presentation, reporting an EPS of $0.82, which missed by $0.30, and revenue of $2.78 billion, beating by $89.47 million with a 0.62% year-over-year increase. This presentation is available for investors interested in …

Why Are International Flavors & Fragrances (IFF) Shares Soaring Today

Vornado Realty Trust Earnings Call Highlights New York Rebound

Vornado Realty Trust (VNO) reported a strong Q2 2026, beating analyst expectations with improved FFO and significant leasing activity in Manhattan. The company highlighted a rebound in core operations, particularly in the PENN District, and a robust leasing pipeline. Despite challenges like higher interest …

IFF Divests Food Ingredients Business in Strategic Shift

International Flavors & Fragrances (IFF) is strategically divesting its Food Ingredients business to CVC Capital Partners, retaining a 10% minority stake for future collaboration. This move, combined with an earlier sale of its Soy Crush unit, is part of a portfolio shift aiming to …

Vor Biopharma investors brace for earnings after massive Q1 loss By Investing.com

Vor Biopharma (NASDAQ: VOR) is set to report its second-quarter results, with investors keenly watching for improvements after a significant first-quarter loss. Analysts project a loss of 73 cents per share, a substantial improvement from the previous quarter's $5.11 loss, and maintain an optimistic …

Vornado, Citadel’s 350 Park lands $3.3B financing

Vornado Realty Trust and its partners, Citadel and Rudin, have secured a $3.3 billion financing package for their 2 million-square-foot office development at 350 Park Avenue, marking one of New York City's largest construction loans. This financing, while substantial, is less than half of …

International Flavors & Fragrances (IFF) Jumps 8.4% to $87.67

International Flavors & Fragrances (IFF) saw an 8.4% surge in its stock price, closing at $87.67, driven by the announcement of a $2.5 billion stock buyback program, despite missing second-quarter earnings expectations. This strategic move, coupled with ongoing portfolio transformation efforts, indicates management's confidence …

International Flavors Q2 Earnings Miss Estimates, Sales Rise Y/Y

International Flavors & Fragrances Inc. (IFF) reported Q2 2026 adjusted earnings of 82 cents per share, missing consensus estimates, though net sales rose 1.8% year-over-year to $1.95 billion, also falling short of estimates. The company's sales growth was driven by its Taste, Health & …

Earnings call transcript: IFF shares rise after Q2 2026 miss, portfolio reset

Bunge (BG) reported strong second-quarter 2026 earnings, with adjusted EPS of $2, up from $1.31 in the prior year, driven by diversification across crops and geographies, particularly in soy and softseed processing. The company raised its full-year 2026 adjusted EPS outlook to a range …

Is International Flavors & Fragrances (IFF) Undervalued After Mixed Q2 Results And New 2026 Guidance?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. International Flavors & Fragrances (IFF) released second quarter 2026 results that combined higher sales with sharply lower earnings and fresh full year guidance, giving investors …

RenovoRx to Present TAMP Platform, TIGeR-PaC Trial Update at JonesTrading Webinar Aug 13

RenovoRx will present its TAMP platform and provide an update on the TIGeR-PaC trial at a JonesTrading webinar on August 13. CEO Shaun Bagai and oncology KOLs will discuss the RenovoCath and the company's commercial progress, including sales figures and growth plans. The webinar …

Empowered Funds LLC Acquires 28,366 Shares of International Flavors & Fragrances Inc. $IFF

Empowered Funds LLC significantly increased its stake in International Flavors & Fragrances Inc. (NYSE:IFF) by 199.6%, purchasing an additional 28,366 shares. This acquisition brings their total holdings to 42,577 shares, valued at $3.089 million. Other institutional investors also adjusted their positions in IFF, which …

Vornado Realty Trust (VNO) Stock Gains Attention As FFO Strengthens Margins Stay Thin

Vornado Realty Trust (VNO) saw its stock rise 2.5% following a strong Q2 earnings report, with Funds From Operations (FFO) reaching US$0.83 per share, exceeding expectations. This positive FFO trend, driven by premium Manhattan assets and the Penn District, is seen by some as …